D I Marks

3.0k total citations
47 papers, 1.6k citations indexed

About

D I Marks is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, D I Marks has authored 47 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Hematology, 15 papers in Immunology and 13 papers in Oncology. Recurrent topics in D I Marks's work include Hematopoietic Stem Cell Transplantation (28 papers), Acute Lymphoblastic Leukemia research (11 papers) and Acute Myeloid Leukemia Research (10 papers). D I Marks is often cited by papers focused on Hematopoietic Stem Cell Transplantation (28 papers), Acute Lymphoblastic Leukemia research (11 papers) and Acute Myeloid Leukemia Research (10 papers). D I Marks collaborates with scholars based in United Kingdom, United States and Australia. D I Marks's co-authors include R. M. Fox, Hillard M. Lazarus, Bronwen E. Shaw, Antonio Pagliuca, Olle Ringdén, Jane F. Apperley, Adele K. Fielding, Christopher Bredeson, Mary M. Horowitz and Sergio Giralt and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

D I Marks

46 papers receiving 1.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
D I Marks 1.2k 505 462 387 241 47 1.6k
Yasunori Ueda 1.1k 1.0× 699 1.4× 289 0.6× 410 1.1× 272 1.1× 115 1.6k
Riccardo Varaldo 1.1k 1.0× 298 0.6× 357 0.8× 536 1.4× 249 1.0× 56 1.5k
Margit Mitterbauer 1.1k 0.9× 272 0.5× 462 1.0× 298 0.8× 225 0.9× 67 1.7k
Edward Kanfer 1.1k 1.0× 250 0.5× 416 0.9× 477 1.2× 394 1.6× 55 1.8k
Ira Braunschweig 1.4k 1.2× 324 0.6× 635 1.4× 642 1.7× 283 1.2× 76 2.0k
Ken Tabuchi 1.1k 1.0× 465 0.9× 334 0.7× 296 0.8× 165 0.7× 52 1.5k
K. F. Bradstock 1.1k 0.9× 512 1.0× 532 1.2× 488 1.3× 281 1.2× 49 1.9k
Norbert Frickhofen 1.0k 0.9× 175 0.3× 414 0.9× 412 1.1× 320 1.3× 34 1.9k
Roberto Crocchiolo 1.2k 1.0× 289 0.6× 661 1.4× 587 1.5× 211 0.9× 111 2.1k
Aloysius Ho 1.0k 0.9× 251 0.5× 322 0.7× 329 0.9× 332 1.4× 91 1.5k

Countries citing papers authored by D I Marks

Since Specialization
Citations

This map shows the geographic impact of D I Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D I Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D I Marks more than expected).

Fields of papers citing papers by D I Marks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D I Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D I Marks. The network helps show where D I Marks may publish in the future.

Co-authorship network of co-authors of D I Marks

This figure shows the co-authorship network connecting the top 25 collaborators of D I Marks. A scholar is included among the top collaborators of D I Marks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D I Marks. D I Marks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Bartels, H., et al.. (2023). Using a Novel Method to Quantify and Confirm the Variable Vertical Vector of the Deep Plane Facelift. Facial Plastic Surgery & Aesthetic Medicine. 26(2). 130–134. 1 indexed citations
3.
Patel, Bijendra, Amy A. Kirkwood, Aditi Dey, et al.. (2016). Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial. Leukemia. 31(1). 58–64. 88 indexed citations
4.
Riches, Marcie, Steven Trifilio, Kwang Woo Ahn, et al.. (2015). Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis. Bone Marrow Transplantation. 51(2). 277–282. 24 indexed citations
5.
Morley, Nicholas & D I Marks. (2015). Inotuzumab ozogamicin in the management of acute lymphoblastic leukaemia. Expert Review of Anticancer Therapy. 16(2). 159–164. 5 indexed citations
6.
Olsson, Richard F., Brent R. Logan, Sonali Chaudhury, et al.. (2015). Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies. Leukemia. 29(8). 1754–1762. 78 indexed citations
7.
Dignan, Fiona L., Julia Scarisbrick, Bronwen E. Shaw, et al.. (2014). Impact of extracorporeal photopheresis on skin scores and quality of life in patients with steroid-refractory chronic GVHD. Bone Marrow Transplantation. 49(5). 704–708. 23 indexed citations
8.
Akpek, Görgün, Marcelo C. Pasquini, Brent R. Logan, et al.. (2012). Effects of spleen status on early outcomes after hematopoietic cell transplantation. Bone Marrow Transplantation. 48(6). 825–831. 52 indexed citations
10.
11.
Malladi, Ram, Andy Peniket, Tim Littlewood, et al.. (2008). Alemtuzumab markedly reduces chronic GVHD without affecting overall survival in reduced-intensity conditioning sibling allo-SCT for adults with AML. Bone Marrow Transplantation. 43(9). 709–715. 22 indexed citations
12.
Cook, Gordon, Jenny Bird, & D I Marks. (2008). In pursuit of the allo-immune response in multiple myeloma: where do we go from here?. Bone Marrow Transplantation. 43(2). 91–99. 8 indexed citations
13.
Shaw, Bronwen E., G J Mufti, Stephen Mackinnon, et al.. (2008). Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant. Bone Marrow Transplantation. 42(12). 783–789. 76 indexed citations
15.
Feyler, Sylvia, H. Miles Prince, Rachel Pearce, et al.. (2007). The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study. Bone Marrow Transplantation. 40(5). 443–450. 71 indexed citations
16.
Duarte, Rafael F., DH Pamphilon, J Cornish, et al.. (2006). Topical issues in unrelated donor haematopoietic stem cell transplants: a report from a workshop convened by the Anthony Nolan Trust in London – 2005. Bone Marrow Transplantation. 37(10). 901–908. 2 indexed citations
17.
Eapen, Mary, Sergio Giralt, Mary M. Horowitz, et al.. (2004). Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. Bone Marrow Transplantation. 34(8). 721–727. 152 indexed citations
19.
Marks, D I, et al.. (1997). Vesicle movement in rat hepatocytes is reduced by ethanol exposure: Alterations in microtubule-based motor enzymes. Gastroenterology. 113(6). 1938–1948. 33 indexed citations
20.
Marks, D I, et al.. (1990). Mechanisms of lymphocytotoxicity induced by extracorporeal photochemotherapy for cutaneous T cell lymphoma.. Journal of Clinical Investigation. 86(6). 2080–2085. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026